Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
We tested the hypothesis that insulin therapy rather than sulfonylurea (SU) treatment has a
preferable outcome to reverse or preserve beta cell function in the patients with diabetes
that is called slowly progressive insulin-dependent (type 1) diabetes (SPIDDM) or latent
autoimmune diabetes in adult (LADA).